marijuana stocks

Tilray to Report Fourth Quarter and Full Fiscal Year 2018 Financial Results on March 18, 2019

Tilray Inc. (TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the fourth quarter and full fiscal year ended December 31, 2018 on Monday, March 18, 2019 after market close.

The Company will host a conference call to discuss these results at 5:00 p.m. ET. Investors interested in participating in the live call can dial 877-489-6528 from the U.S. and 629-228-0736 internationally. A telephone replay will be available approximately two hours after the call concludes through Monday, April 1, 2019, by dialing 855-859-2056 from the U.S., or 404-537-3406 from international locations, and entering confirmation code 6093459.

There will also be a simultaneous, live webcast available on the Investors section of the Company’s website at www.tilray.com. The webcast will be archived for 30 days.

About Tilray®

Tilray (TLRY) is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in twelve countries spanning five continents.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$MNTR CEO Talks Cannabis in Forbes

Mentor Capital CEO Discusses Marijuana Investment in Forbes Magazine In “Why Legalizing…

Namaste Technologies Inc. (NXTTF) Announces Record-Breaking November 2018 Revenue

Namaste Announces Record-Breaking November 2018 Revenue of $2.6 Million Representing 52% Monthly…

The Supreme Cannabis Company, Inc. (SPRWF) Signs LOI with Malta Enterprises for Cannabis License

Supreme Cannabis Signs LOI with Malta Enterprises for Cannabis License The Supreme…

Tilray Brands, Inc. (TLRY) Granted Approval to Introduce Third Medical Cannabis Product in Portugal

Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal…